Thus, elucidation of the regulatory mechanism underlying the LINC00606/miR-486-3p/TCF12/ATP11B axis may lay the foundation for the discovery of new therapeutic strategies for GBM. This evidence concerns the gene LINC00606 and glioblastoma.